Circulating sclerostin levels and cardiovascular risk in obesity

Int J Cardiol. 2016 Jul 1:214:48-50. doi: 10.1016/j.ijcard.2016.03.072. Epub 2016 Mar 24.

¹ Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center of Vojvodina, Medical Faculty, University of Novi Sad, Hajduk Veljkova 1, 21000 Novi Sad, Serbia. Electronic address: pitstop021@gmail.com.
² Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center of Vojvodina, Medical Faculty, University of Novi Sad, Hajduk Veljkova 1, 21000 Novi Sad, Serbia.
³ Emergency Center, Clinical Center of Vojvodina, Medical Faculty, University of Novi Sad, Hajduk Veljkova 1, 21000 Novi Sad, Serbia.

No abstract available

Keywords: Cardiovascular risk; Metabolic syndrome; Obesity; Prediabetes; Sclerostin.

MeSH terms